University of Wisconsin-Madison since 1994
Professor
UW Dec 1994 - 2011
Professor of Cell and Regenerative Biology, Affiliate Professor of Medicine (Hematology/Oncology)
Education:
University of Michigan Medical School 1984 - 1989
Doctorates, Doctor of Philosophy, Philosophy
Skills:
Biochemistry Cell Biology Research Cell Culture Genetics Western Blotting Protein Chemistry Molecular Biology
Us Patents
Compositions And Methods For Modulating Angiogenesis
Emery Bresnick - Madison WI, US Soumen Paul - Madison WI, US
International Classification:
A61K 38/17 A61K 38/22 A61K 38/12
US Classification:
514009000, 514012000, 514015000
Abstract:
Methods and compositions for modulating angiogenesis are disclosed. Such modulation is made possible by the use of NK-B, NK-B analogs, NK receptor agonists and NK receptor antagonists to promote or inhibit angiogenesis. The method for modulating the angiogenic activity of cells comprises contacting cells capable of angiogenesis with an effective amount of NK-B, an NK-B analog, an NK receptor agonist or an NK receptor antagonist wherein the angiogenic activity of the cells is increased or decreased. The angiogenesis modulating compounds can be administered to alleviate and or prevent angiogenesis related diseases in patients, such as, for example, cancer, rheumatoid arthritis, macular degeneration, atherosclerosis, coronary artery disease, peripheral vascular disease, varicose veins and preeclampsia.
Agents And Methods For Modulating Activator Protein-1-Mediated Cellular Processes
Emery Bresnick - Middleton WI, US Jason Norton - Madison WI, US Jianlin Chu - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation
International Classification:
A61K038/17 C12Q001/68 G01N033/53 G01N033/567
US Classification:
514/012000, 435/006000, 435/007200
Abstract:
Agents for modulating AP-1 mediated gene expression are provided. The modulating agents comprise an internalization moiety and: (1) a peptide sequence isolated from the intracellular domain of Notch-1 (NIC-1); or (2) a peptide analogue or peptidomimetic of the NIC-1 peptide sequence. Methods of using the modulating agents for modulating AP-1 mediated gene expression in a variety of contexts (e.g., for modulating inflammatory and immunosuppressive activities) are provided.